Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Pembrolizumab in Unresectable Hepatocellular Carcinoma: NCT07412054 Clinical Landscape Report 2026
15 October 2026
NCT07412054 clinical landscape for Unresectable Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Claudin18.2 Targeted CAR-T Cells(Frontiergate Biopharm) in Pancreatic Cancer: NCT07416240 Clinical Landscape Report 2026
15 October 2026
NCT07416240 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
SYS-6043 in Ovarian Cancer: NCT07424547 Clinical Landscape Report 2026
15 October 2026
NCT07424547 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KT032 in Ovarian Cancer: NCT07420010 Clinical Landscape Report 2026
15 October 2026
NCT07420010 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Duloxetine Hydrochloride in Inflammatory Bowel Diseases: NCT07431606 Clinical Landscape Report 2026
15 October 2026
NCT07431606 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Infliximab in Pediatric Crohn's Disease: NCT07424040 Clinical Landscape Report 2026
15 October 2026
NCT07424040 clinical landscape for Pediatric Crohn's Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab N01 in Advanced Hepatocellular Carcinoma: NCT07422753 Clinical Landscape Report 2026
15 October 2026
NCT07422753 clinical landscape for Advanced Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spa…
9 min read
CL-NK-003 in Pancreatic Cancer: NCT07425483 Clinical Landscape Report 2026
15 October 2026
NCT07425483 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
POZ-apomorphine(Serina Therapeutics) in Young onset Parkinson disease: NCT07422675 Clinical Landscape Report 2026
15 October 2026
NCT07422675 clinical landscape for Young onset Parkinson disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PALI-2108 in Crohn Disease: NCT07428096 Clinical Landscape Report 2026
15 October 2026
NCT07428096 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PVT-401 in Inflammatory Bowel Diseases: NCT07423000 Clinical Landscape Report 2026
15 October 2026
NCT07423000 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Fibrolamellar Hepatocellular Carcinoma: NCT07430202 Clinical Landscape Report 2026
15 October 2026
NCT07430202 clinical landscape for Fibrolamellar Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…